Have your own idea? Try our Stock Screener
Over the last 7 days, the Pharma industry has dropped 1.9%, driven by a pullback from Lumosa Therapeutics of 9.4%. On the other hand Caliway Biopharmaceuticals is actually up 6.3%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 8.7% annually.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 21 Jan 2025 | NT$605.6b | NT$109.3b | NT$11.4b | 21.1x | 53x | 5.5x |
Thu, 19 Dec 2024 | NT$580.8b | NT$101.2b | NT$11.8b | 21.5x | 49.3x | 5.7x |
Sat, 16 Nov 2024 | NT$620.1b | NT$106.3b | NT$9.3b | 24.8x | 66.5x | 5.8x |
Mon, 14 Oct 2024 | NT$619.3b | NT$104.7b | NT$8.9b | 27.3x | 69.3x | 5.9x |
Wed, 11 Sep 2024 | NT$630.3b | NT$104.7b | NT$8.9b | 24.4x | 70.5x | 6x |
Fri, 09 Aug 2024 | NT$617.5b | NT$100.5b | NT$6.8b | 28.1x | 90.4x | 6.1x |
Sun, 07 Jul 2024 | NT$708.6b | NT$100.5b | NT$6.8b | 32.6x | 103.8x | 7x |
Tue, 04 Jun 2024 | NT$627.8b | NT$100.4b | NT$7.1b | 29.8x | 87.8x | 6.3x |
Thu, 02 May 2024 | NT$627.4b | NT$101.8b | NT$9.4b | 25.5x | 67x | 6.2x |
Sat, 30 Mar 2024 | NT$646.3b | NT$101.2b | NT$9.4b | 26.6x | 69x | 6.4x |
Mon, 26 Feb 2024 | NT$641.5b | NT$101.6b | NT$8.2b | 23.9x | 78.7x | 6.3x |
Wed, 24 Jan 2024 | NT$588.5b | NT$101.9b | NT$7.8b | 24x | 75.5x | 5.8x |
Fri, 22 Dec 2023 | NT$579.3b | NT$101.6b | NT$7.6b | 23.6x | 76x | 5.7x |
Sun, 19 Nov 2023 | NT$561.7b | NT$101.8b | NT$8.4b | 24.5x | 66.5x | 5.5x |
Tue, 17 Oct 2023 | NT$536.6b | NT$101.7b | NT$9.6b | 20.9x | 55.8x | 5.3x |
Thu, 14 Sep 2023 | NT$551.1b | NT$101.7b | NT$9.6b | 22.5x | 57.3x | 5.4x |
Sat, 12 Aug 2023 | NT$556.9b | NT$98.7b | NT$10.1b | 17.3x | 55.2x | 5.6x |
Mon, 10 Jul 2023 | NT$581.6b | NT$98.7b | NT$10.1b | 16.9x | 57.8x | 5.9x |
Wed, 07 Jun 2023 | NT$585.1b | NT$98.4b | NT$10.0b | 16.7x | 58.5x | 5.9x |
Fri, 05 May 2023 | NT$586.9b | NT$92.1b | NT$8.6b | 23.2x | 68.4x | 6.4x |
Sun, 02 Apr 2023 | NT$569.0b | NT$91.5b | NT$8.7b | 20.7x | 65.8x | 6.2x |
Tue, 28 Feb 2023 | NT$559.2b | NT$84.7b | NT$7.6b | 23.6x | 73.3x | 6.6x |
Thu, 26 Jan 2023 | NT$484.3b | NT$84.6b | NT$7.9b | 20.6x | 61.4x | 5.7x |
Sat, 24 Dec 2022 | NT$505.4b | NT$84.6b | NT$7.9b | 23.1x | 64.1x | 6x |
Mon, 21 Nov 2022 | NT$451.5b | NT$84.6b | NT$7.7b | 15.8x | 58.9x | 5.3x |
Wed, 19 Oct 2022 | NT$410.3b | NT$78.9b | NT$4.3b | 17.3x | 94.8x | 5.2x |
Fri, 16 Sep 2022 | NT$462.1b | NT$78.9b | NT$4.3b | 18.5x | 106.8x | 5.9x |
Sun, 14 Aug 2022 | NT$394.8b | NT$77.3b | NT$4.9b | 20.5x | 81.2x | 5.1x |
Tue, 12 Jul 2022 | NT$384.5b | NT$76.8b | NT$4.4b | 21.9x | 88x | 5x |
Thu, 09 Jun 2022 | NT$378.5b | NT$76.8b | NT$4.4b | 20.6x | 86.6x | 4.9x |
Sat, 07 May 2022 | NT$387.6b | NT$76.6b | NT$6.5b | 21.1x | 59.2x | 5.1x |
Mon, 04 Apr 2022 | NT$406.3b | NT$76.4b | NT$6.8b | 20.6x | 59.8x | 5.3x |
Wed, 02 Mar 2022 | NT$408.2b | NT$76.5b | NT$8.7b | 19.9x | 46.9x | 5.3x |
Fri, 28 Jan 2022 | NT$378.7b | NT$76.7b | NT$8.5b | 18.9x | 44.7x | 4.9x |
44.7x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | 3.46% | |
Healthcare | 0.0098% | |
Pharma | 0.46% | |
Pharma | 0.46% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6919 Caliway Biopharmaceuticals | NT$703.00 | 12.3% +NT$11.8b | 237.2% | PS2158.3x | |
6932 Mercury Biopharmaceutical | NT$15.70 | 38.3% +NT$1.8b | -11.5% | PS1150.4x | |
6472 Bora Pharmaceuticals | NT$818.00 | 1.5% +NT$1.2b | 22.8% | PE21.7x | |
6620 Handa Pharmaceuticals | NT$78.20 | 11.2% +NT$1.1b | -55.3% | PE24.4x | |
1789 ScinoPharm Taiwan | NT$22.35 | 1.6% +NT$276.8m | -12.4% | PE44.3x |